Literature DB >> 25407320

Reversible infantile mitochondrial diseases.

Veronika Boczonadi1, Boglarka Bansagi, Rita Horvath.   

Abstract

Mitochondrial diseases are usually severe and progressive conditions; however, there are rare forms that show remarkable spontaneous recoveries. Two homoplasmic mitochondrial tRNA mutations (m.14674T>C/G in mt-tRNA(Glu)) have been reported to cause severe infantile mitochondrial myopathy in the first months of life. If these patients survive the first year of life by extensive life-sustaining measures they usually recover and develop normally. Another mitochondrial disease due to deficiency of the 5-methylaminomethyl-2-thiouridylate methyltransferase (TRMU) causes severe liver failure in infancy, but similar to the reversible mitochondrial myopathy, within the first year of life these infants may also recover completely. Partial recovery has been noted in some other rare forms of mitochondrial disease due to deficiency of mitochondrial tRNA synthetases and mitochondrial tRNA modifying enzymes. Here we summarize the clinical presentation of these unique reversible mitochondrial diseases and discuss potential molecular mechanisms behind the reversibility. Understanding these mechanisms may provide the key to treatments of potential broader relevance in mitochondrial disease, where for the majority of the patients no effective treatment is currently available.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25407320     DOI: 10.1007/s10545-014-9784-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  39 in total

1.  Vascular involvement in benign infantile mitochondrial myopathy caused by reversible cytochrome c oxidase deficiency.

Authors:  H Wada; M Woo; H Nishio; S Nagaki; H Yanagawa; A Imamura; S Yokoyama; C Ohbayashi; M Matsuo; H Itoh; H Nakamura
Journal:  Brain Dev       Date:  1996 Jul-Aug       Impact factor: 1.961

Review 2.  Human diseases with impaired mitochondrial protein synthesis.

Authors:  Agnès Rötig
Journal:  Biochim Biophys Acta       Date:  2011-06-25

3.  Mitochondrial Infantile Liver Disease due to TRMU Gene Mutations: Three New Cases.

Authors:  Pauline Gaignard; Emmanuel Gonzales; Oanez Ackermann; Philippe Labrune; Isabelle Correia; Patrice Therond; Emmanuel Jacquemin; Abdelhamid Slama
Journal:  JIMD Rep       Date:  2013-04-27

4.  Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy.

Authors:  Carlo Viscomi; Alberto B Burlina; Imad Dweikat; Mario Savoiardo; Costanza Lamperti; Tatjana Hildebrandt; Valeria Tiranti; Massimo Zeviani
Journal:  Nat Med       Date:  2010-07-25       Impact factor: 53.440

5.  Liver mtDNA content increases during development: a comparison of methods and the importance of age- and tissue-specific controls for the diagnosis of mtDNA depletion.

Authors:  Karl J Morten; Neil Ashley; Frits Wijburg; Nedim Hadzic; Jeremy Parr; Sandeep Jayawant; Susan Adams; Laurence Bindoff; Henk D Bakker; Giorgina Mieli-Vergani; Massimo Zeviani; Joanna Poulton
Journal:  Mitochondrion       Date:  2007-09-21       Impact factor: 4.160

6.  Plasma thiol status is altered in children with mitochondrial diseases.

Authors:  Heli Salmi; James V Leonard; Shamima Rahman; Risto Lapatto
Journal:  Scand J Clin Lab Invest       Date:  2012-01-02       Impact factor: 1.713

7.  Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.

Authors:  Nichola Z Lax; Sharmilee Gnanapavan; Sarah J Dowson; Charlotte L Alston; Langping He; Tuomo M Polvikoski; Evelyn Jaros; Dominic G O'Donovan; John W Yarham; Douglass M Turnbull; Andrew F Dean; Robert W Taylor
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

8.  Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation.

Authors:  Joanna Rorbach; Abdul Aziz Yusoff; Helen Tuppen; Dyg P Abg-Kamaludin; Zofia M A Chrzanowska-Lightowlers; Robert W Taylor; Douglass M Turnbull; Robert McFarland; Robert N Lightowlers
Journal:  Nucleic Acids Res       Date:  2008-04-08       Impact factor: 16.971

9.  Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency.

Authors:  Veronika Boczonadi; Paul M Smith; Angela Pyle; Aurora Gomez-Duran; Ulrike Schara; Mar Tulinius; Patrick F Chinnery; Rita Horvath
Journal:  Hum Mol Genet       Date:  2013-06-28       Impact factor: 6.150

10.  MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast.

Authors:  Enrico Baruffini; Cristina Dallabona; Federica Invernizzi; John W Yarham; Laura Melchionda; Emma L Blakely; Eleonora Lamantea; Claudia Donnini; Saikat Santra; Suresh Vijayaraghavan; Helen P Roper; Alberto Burlina; Robert Kopajtich; Anett Walther; Tim M Strom; Tobias B Haack; Holger Prokisch; Robert W Taylor; Ileana Ferrero; Massimo Zeviani; Daniele Ghezzi
Journal:  Hum Mutat       Date:  2013-09-17       Impact factor: 4.878

View more
  15 in total

1.  Next generation mitochondrial disease: change in diagnostics with eyes on therapy.

Authors:  Eva Morava; Garry K Brown
Journal:  J Inherit Metab Dis       Date:  2015-05       Impact factor: 4.982

2.  Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency.

Authors:  Mariella T Simon; Bobby G Ng; Marisa W Friederich; Raymond Y Wang; Monica Boyer; Martin Kircher; Renata Collard; Kati J Buckingham; Richard Chang; Jay Shendure; Deborah A Nickerson; Michael J Bamshad; Johan L K Van Hove; Hudson H Freeze; Jose E Abdenur
Journal:  Mitochondrion       Date:  2017-02-12       Impact factor: 4.160

Review 3.  Emerging aspects of treatment in mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2015-05-12       Impact factor: 4.982

Review 4.  Applying genomic and transcriptomic advances to mitochondrial medicine.

Authors:  William L Macken; Jana Vandrovcova; Michael G Hanna; Robert D S Pitceathly
Journal:  Nat Rev Neurol       Date:  2021-02-23       Impact factor: 42.937

5.  TRMU deficiency: A broad clinical spectrum responsive to cysteine supplementation.

Authors:  Chaya N Murali; Claudia Soler-Alfonso; Kathleen M Loomes; Amit A Shah; Danielle Monteil; Carmencita D Padilla; Fernando Scaglia; Rebecca Ganetzky
Journal:  Mol Genet Metab       Date:  2021-01-14       Impact factor: 4.797

6.  Expression pattern of mitochondrial respiratory chain enzymes in skeletal muscle of patients with mitochondrial myopathy associated with the homoplasmic m.14674T>C variant.

Authors:  Sara Roos; Carola Hedberg-Oldfors; Kittichate Visuttijai; My Stein; Gittan Kollberg; Ólöf Elíasdóttir; Christopher Lindberg; Niklas Darin; Anders Oldfors
Journal:  Brain Pathol       Date:  2021-11-21       Impact factor: 7.611

7.  Reduced TRMU expression increases the sensitivity of hair-cell-like HEI-OC-1 cells to neomycin damage in vitro.

Authors:  Zuhong He; Shan Sun; Muhammad Waqas; Xiaoli Zhang; Fuping Qian; Cheng Cheng; Mingshu Zhang; Shasha Zhang; Yongming Wang; Mingliang Tang; Huawei Li; Renjie Chai
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

8.  Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy.

Authors:  Irene Tosi; Tatiana Art; Dominique Cassart; Frédéric Farnir; Justine Ceusters; Didier Serteyn; Hélène Lemieux; Dominique-Marie Votion
Journal:  J Bioenerg Biomembr       Date:  2018-08-24       Impact factor: 2.945

9.  Mtu1-Mediated Thiouridine Formation of Mitochondrial tRNAs Is Required for Mitochondrial Translation and Is Involved in Reversible Infantile Liver Injury.

Authors:  Yong Wu; Fan-Yan Wei; Layla Kawarada; Takeo Suzuki; Kimi Araki; Yoshihiro Komohara; Atsushi Fujimura; Taku Kaitsuka; Motohiro Takeya; Yuichi Oike; Tsutomu Suzuki; Kazuhito Tomizawa
Journal:  PLoS Genet       Date:  2016-09-30       Impact factor: 5.917

Review 10.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.